Your session is about to expire
← Back to Search
Crystalloid Solutions for Septic Shock (FISSH Trial)
FISSH Trial Summary
This trial will compare the effects of low chloride and normal chloride solutions on mortality and AKI in septic shock patients.
FISSH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFISSH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FISSH Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this clinical trial being conducted in multiple locations within the city?
"There are 17 sites where this trial is being conducted, they are: Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ) in Trois-Rivières, Brantford General Hospital in Brantford, Hamilton General Hospital in Hamilton, and 14 other locations."
Could you give an estimate as to how many individuals are currently enrolled in this trial?
"Yes, recruitment for this trial is still open according to the latest update on clinicaltrials.gov. The posting date was September 9th, 2018, and the 17 locations are recruiting 1096 patients in total."
Can patients sign up for this experiment right now?
"Yes, you are correct. The trial is currently ongoing and recruiting patients from 17 different sites. 1096 individuals are needed for the study."
What are the objectives of this experiment?
"The main metric that will be used to assess the success of this 30-day clinical trial is 30-day mortality rates. Additionally, hospital/ICU mortality rates, serum potassium levels outside the normal range, and duration of vasoactive agent use will be monitored as secondary outcomes."
Share this study with friends
Copy Link
Messenger